Skip to content

A STUDY TO KNOW THE PAIN RELIEVING EFFECT OF INTRAVENOUS MAGNESIUM SULPHATE AFTER BELOW UMBILICAL OPERATION UNDER SPINAL REGIONAL ANAESTHESIA

A DOUBLE BLINDED RANDOMISED, CONTROL TRIAL TO EVALUATE THE POST-OPERATIVE ANALGESIC EFFECT OF I.V. MAGNESIUM SULPHATE IN INFRA UMBILICAL SURGERIES UNDER SUB-ARACHNOID BLOCK

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/08/027028
Enrollment
80
Registered
2020-08-07
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: I.V. MAGNESIUM SULPHATE IN INFRA-UMBILICAL SURGERIES UNDER SUB-ARACHNOID BLOCK.: Pre-operative MgSO4 bolus dose will be given 50mg/Kg in 10ml of Isotonic Normal Saline(NS) over 10mins s

Sponsors

MIDNAPORE MEDICAL COLLEGE HOSPITAL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: i) Patients of ASA grade I & II criteria. ii) Age between 15 to 65 years. iii) Patients understand procedure & can give written consent. iv) Patients who understand VAS score. v) Patients hemodynamically stable.

Exclusion criteria

Exclusion criteria: i) Cases contra-indicated for sub-arachnoid block. ii) Pregnant and Lactating mother. iii) Patients with H/O MgSO4 allergy. iv) Patients with drug and alcohol abuse. v) Patients on treatment with calcium channel blocker. vi) Patients having liver disease. vii) Patients having cardiac disease. viii) Hematological disorders or Musculo-skeletal disorders. ix) Patients having renal disease. x) Neurological deficit / Psychological disorder. xi) Uncontrolled D2M. xii) Immunocompromised patients. xiii) Failed spinal converted to General anesthesia.

Design outcomes

Primary

MeasureTime frame
Expect that it will prolong the duration of demand the first rescue analgesia and also reduce total post-operative analgesic requirements of analgesic drugs during the first 48 hour.Timepoint: JUNE 2020 TO AUGUST 2021.

Secondary

MeasureTime frame
i)To compare the onset and maximum level of sensory block. ii)To compare onset, quality and duration of motor block. iii)To observe hemodynamic parameters like hypotension, bradycardia, sedation and respiratory depression.Timepoint: JUNE 2020 TO AUGUST 2021.

Countries

India

Contacts

Public ContactDR BAISAKHI LAHA

R G KAR MEDICAL COLLEGE AND HOSPITAL

banihembrom72@gmail.com9903207690

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026